Thoracic Vascular Stent Grafts Market Share

North America Market Forecast

North America industry is predicted to hold largest revenue share by 2037. The growth of the market can be attributed majorly to the significant rise in the aged population, coupled with the high prevalence of cardiovascular diseases (CVDs) in the region. According to the Centers for Disease Control and Prevention, in the United States, heart disease accounted for the deaths of about 697,000 people in 2020. Besides this, nearly 20.1 million adults aged 20 and above are influenced by coronary artery disease. Further, the dynamically surging technological developments, along with the availability of favorable reimbursement policies, are some further factors that are projected to accelerate the market’s growth during the forecast period in the region.

Asia Pacific Market Forecast

Further, the Asia Pacific thoracic vascular stent grafts market is also anticipated to display prominent market growth by the end of 2037. The growth of the market can be attributed to the dynamically increasing demand for minimally invasive surgical procedures, coupled with the surge in the ratio of patients with cardiovascular diseases in the region. For instance, in 2019, CVDs were the major cause of mortality in Asia, accounting for around 11 million deaths, or nearly 38% of overall deaths in the region. Along with this, the huge surge in chronic kidney disease, and growing healthcare infrastructure are some significant factors that are estimated to propel the market growth in the region in the projected time frame. In addition, a notable increase in favorable reimbursement policies is also anticipated to propel the market growth during the forecast period in the region.